Table 1.
Variable | Number | Univariate analysis | Multivariate | |
---|---|---|---|---|
P value | HR (95% CI) | P value | ||
Tumour HNF-1B expression | ||||
Low vs High | 57 vs 33 | 0.001* | 2.406 (1.415,4.092) | 0.007* |
Tumour size | ||||
<5 cm vs ≥ 5 cm | 38 vs 52 | 0.010* | NS | |
Tumour number | ||||
Single vs Multiple | 92 vs 8 | 0.339 | NA | |
Cirrhosis | ||||
No vs Yes | 24 vs 66 | 0.001* | NS | |
TNM stage | ||||
I/II vs III | 82 vs 8 | 0.005* | 3.596 (1.388,9.314) | 0.008* |
HbsAg | ||||
Negative vs Positive | 74 vs 16 | 0.794 | NA | |
Serum AFP | ||||
<400 vs ≥400 | 67 vs 23 | 0.499 | NA | |
Edmondson grade | ||||
I/II vs III | 62 vs 28 | 0.021* | 1.776 (1.086,2.907) | 0.022* |
Encapsulation | ||||
No vs Yes | 26 vs 64 | 0.142 | NA | |
Portal vein thrombosis | ||||
No vs Yes | 65 vs 25 | 0.147 | NA | |
Microvascular invasion | ||||
No vs Yes | 35 vs 55 | 0.451 | NA | |
Macrovascular invasion | ||||
No vs Yes | 85 vs 5 | 0.005* | NS |
NA, not adopted; NS, not significant; HR, hazard ratio; Factors with p < 0.05 in univariate analysis were used for further multivariate analysis. *P < 0.05 was considered statistically significant.